Recent & Archived News
August 01, 2019
Bayer Extends Multi-Year Partnership with Luke Bryan and its Commitment to its Here's to the Farmer Campaign
After donating close to 3 million meals across the United States, Bayer reaffirmed its partnership and commitment to its Here's to the Farmer campaign with Luke Bryan. Bayer will join the country...
July 30, 2019
FDA approves Bayer's Nubeqa® (darolutamide), a new treatment for men with non-metastatic castration-resistant prostate cancer
The U.S. Food and Drug Administration (FDA) today approved Nubeqa® (darolutamide), an androgen receptor inhibitor (ARi), for the treatment of patients with non-metastatic castration-resistant...
July 24, 2019
Bayer Consumer Health and White Ribbon Alliance Announce Three-Year Renewal of Partnership to Improve the Every Day Health of Women, Infants and Children through Self-Care
Bayer and White Ribbon Alliance today announced they will extend their partnership and expand their initiative to help women in low and middle income countries gain the knowledge and confidence...
July 22, 2019
Daily Aspirin Still Recommended for Millions of Americans Who Have Had a Heart Attack or Ischemic Stroke
In response to the report in today's Annals of Internal Medicine, Bayer realizes there may be confusion around the appropriate use of aspirin, which in the United States is only approved for...
July 22, 2019
Bayer Earns Top Marks in 2019 Disability Equality Index
For the first time, Bayer U.S. earned an 80 in the 2019 Disability Equality Index (DEI), and was recognized as a Best Place to Work for Disability Inclusion. DEI is the most comprehensive...
July 19, 2019
Bayer statement on voluntary recall of two lots of Kogenate® FS antihemophilic factor (recombinant) in the United States
Bayer is voluntarily recalling two lots of Kogenate® FS antihemophilic factor (recombinant) 2000 IU vials in the United States to the patient level. Certain vials from these two lots that were...
July 18, 2019
Bayer Partners with the National Press Foundation to Provide Educational Training Programs for Journalists
As part of its longstanding partnership with the National Press Foundation (NPF), Bayer announced today its sponsorship of two educational programs focused on agriculture and cardiovascular...
July 18, 2019
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with metastatic colorectal cancer
Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. ('Ono') announced today the three companies have entered into a clinical collaboration agreement to evaluate the...
July 17, 2019
Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer
Pyxis Oncology ('Pyxis'), a newly formed immuno-oncology company, launched today with a focus on developing a new family of antibody-based immunotherapies derived from novel insights into the...
July 15, 2019
FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease
Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist® (gadobutrol) injection for use in cardiac magnetic resonance (MR) imaging to assess myocardial perfusion...
Want even more Bayer news?
Last Updated: December 14, 2018